ea0022p131 | Cardiovascular endocrinology and lipid metabolism | ECE2010
Povoroznyuk Vladyslav
, Martynyuk Larisa
, Shved Mykola
, Dzerovych Nataliia
, Vayda Volodymyr
, Martyntyuk Lilya
Objective: The metabolic syndrome (MS), which includes obesity, dyslipidemia, impaired glucose tolerance, and hypertension, is a major public health problem. The prevalence of MS among women in postmenopausal period is nearly 24%. In postmenopausal period the accelerated bone loss, contributing to the development of osteoporosis begins. Obesity or increased body mass index (BMI) is known to have a protective effect against osteoporosis. However, recent studies demonstrated tha...